𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P35 IS THE VASOPRESSIN RELEASE THE CRUCIAL FACTOR IN THE PATHOGENESIS OF HYPERVOLEMIC HYPONATREMIA IN PATIENTS WITH CIRRHOSIS AND ASCITES?

✍ Scribed by Piano, S.; Gola, E.; Sticca, A.; Morando, F.; Cavallin, M.; Rosi, S.; Stanco, M.; Romano, A.; Fasolato, S.; Gatta, A.; Angeli, P.

Book ID
122332764
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
68 KB
Volume
60
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Is this really the end of beta-blockers
Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites?
✍ Thierry Thevenot; Jean-Paul Cervoni; Elisabeth Monnet; Frances Sheppard; Vincent πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 387 KB πŸ‘ 2 views

We read with interest the study by Sola `et al., 1 who found that 39 patients (67%) had a very alarming decrease in their serum sodium levels ! 5 mEq/L during terlipressin treatment for acute variceal bleeding (AVB). We, however, feel that some of their observations may require a closer look by the